The behavioural and neuroprotective outcomes when 670nm and 810nm near infrared light are applied together in MPTP-treated mice
暂无分享,去创建一个
Daniel M. Johnstone | J. Stone | A. Benabid | J. Mitrofanis | N. Torres | C. Chabrol | J. Molet | C. Moro | N. Massri | Florian Reinhart
[1] Daniel M. Johnstone,et al. Near-infrared light (670 nm) reduces MPTP-induced parkinsonism within a broad therapeutic time window , 2016, Experimental Brain Research.
[2] Daniel M. Johnstone,et al. Turning On Lights to Stop Neurodegeneration: The Potential of Near Infrared Light Therapy in Alzheimer's and Parkinson's Disease , 2016, Front. Neurosci..
[3] Daniel M. Johnstone,et al. The effect of different doses of near infrared light on dopaminergic cell survival and gliosis in MPTP-treated mice , 2016, The International journal of neuroscience.
[4] Daniel M. Johnstone,et al. Near‐infrared light is neuroprotective in a monkey model of Parkinson disease , 2016, Annals of neurology.
[5] Y. Tardy,et al. Photobiomodulation Suppresses Alpha-Synuclein-Induced Toxicity in an AAV-Based Rat Genetic Model of Parkinson’s Disease , 2015, PloS one.
[6] Florian Reinhart,et al. 810nm near-infrared light offers neuroprotection and improves locomotor activity in MPTP-treated mice , 2015, Neuroscience Research.
[7] Daniel M. Johnstone,et al. Indirect application of near infrared light induces neuroprotection in a mouse model of parkinsonism – An abscopal neuroprotective effect , 2014, Neuroscience.
[8] Alan R. Harvey,et al. Differential Effects of 670 and 830 nm Red near Infrared Irradiation Therapy: A Comparative Study of Optic Nerve Injury, Retinal Degeneration, Traumatic Brain and Spinal Cord Injury , 2014, PloS one.
[9] Douglas W. Barrett,et al. Augmentation of cognitive brain functions with transcranial lasers , 2014, Front. Syst. Neurosci..
[10] Daniel M. Johnstone,et al. The impact of near-infrared light on dopaminergic cell survival in a transgenic mouse model of parkinsonism , 2013, Brain Research.
[11] Daniel M. Johnstone,et al. Photobiomodulation preserves behaviour and midbrain dopaminergic cells from MPTP toxicity: evidence from two mouse strains , 2013, BMC Neuroscience.
[12] Tianhong Dai,et al. Transcranial Low-Level Laser Therapy Improves Neurological Performance in Traumatic Brain Injury in Mice: Effect of Treatment Repetition Regimen , 2013, PloS one.
[13] J. Stone,et al. Photobiomodulation enhances nigral dopaminergic cell survival in a chronic MPTP mouse model of Parkinson's disease. , 2012, Parkinsonism & related disorders.
[14] Tianhong Dai,et al. The Nuts and Bolts of Low-level Laser (Light) Therapy , 2011, Annals of Biomedical Engineering.
[15] F Gonzalez-Lima,et al. Low-level light therapy of the eye and brain. , 2011, Eye and brain.
[16] M. Wong-Riley,et al. Harnessing the cell's own ability to repair and prevent neurodegenerative disease. , 2008, SPIE newsroom.
[17] Rina Das,et al. Clinical and experimental applications of NIR-LED photobiomodulation. , 2006, Photomedicine and laser surgery.
[18] R. Waynant,et al. Light promotes regeneration and functional recovery and alters the immune response after spinal cord injury , 2005, Lasers in surgery and medicine.
[19] Michele Henry,et al. Mitochondrial signal transduction in accelerated wound and retinal healing by near-infrared light therapy. , 2004, Mitochondrion.
[20] Andreas Schober,et al. Classic toxin-induced animal models of Parkinson’s disease: 6-OHDA and MPTP , 2004, Cell and Tissue Research.
[21] Keyoumars Ashkan,et al. Neuroprotection of midbrain dopaminergic cells in MPTP‐treated mice after near‐infrared light treatment , 2010, The Journal of comparative neurology.